Reeling from a tough stretch, Endo International has inked a deal to put 1,300 testosterone drug liability lawsuits to rest. The company disclosed a "master settlement agreement" on Tuesday to resolve ...

Endo ($ENDP) hasn't quite wrapped up its $8 billion deal for generics maker Par Pharmaceutical, recently agreeing to a loan package to speed things along. Now, the ...

London, Ontario: Dr. John McNaught, FRCSC, OB/GYN, MD and his teams at CReATe Fertility and London Women’s Health Care are ...

Mallinckrodt and Endo said they will merge through a $6.7 billion cash and stock deal creating a combined company that will be intent on bouncing back from their troubled recent histories, stemming ...

In the second-largest fine ever levied on a pharmaceutical company, Endo Health Solutions was ordered to pay nearly $1.1 billion in criminal penalties and another $450 million in criminal forfeiture ...

Endo Health Solutions said today it is acquiring Canadian-based specialty pharma company Paladin Labs for roughly $1.6 billion, in a stock and cash deal that expands the buyer’s global presence, ...

US healthcare company Endo Health Solutions has acquired Canada-based specialty pharma company Paladin Labs in a deal worth up to US $1.6 billion. Paladin Labs focuses on acquiring or in-licensing ...

During the continued wave of life science M&A, companies are seeking to focus on core competencies. Once again, this trend has resulted in Boston Scientific ($BSX ...